ASNRT — Arab Society of Nephrology and Renal Transplantation

Belatacept Pharmacokinetic Analysis of Belatacept Early Steroid Withdrawal Trial (BEST) to Clinical Outcomes and Compared With Reported BENEFIT and BENEFIT-EXT Pharmacokinetic Analysis.

Highlights the latest clinical efficacy and safety data of calcineurin inhibitor-free maintenance regimens in kidney transplant recipients, a high priority for regional transplant centers.

Category

Transplant

Source

Clin Transplant

Read the original article

More from ASNRT News

Browse the latest news, society announcements, KDIGO guideline updates, and AJNT issue releases on the ASNRT newsroom.

All news · ASNRT home